Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Indoco Remedies to report net profit at Rs 38.6 crore up 53.9% year-on-year (down 2.5% quarter-on-quarter).
Net Sales are expected to increase by 24.2 percent Y-o-Y (up 5.1 percent Q-o-Q) to Rs 400.5 crore, according to Prabhudas Lilladher.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 42 percent Y-o-Y (down 4.2 percent Q-o-Q) to Rs 78.1 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.